Medtronic Medical Surgical — Selling, general, and administrative expense increased by 0.2% to $628.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.8%, from $605.00M to $628.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
A lower ratio of SG&A to sales suggests improved operational efficiency and better scalability of the sales organization.
Includes all non-manufacturing costs incurred by the Medical Surgical segment, such as sales force compensation, marketi...
Standard SG&A expense reporting for medical device business units.
mdt_segment_medical_surgical_selling_general_and_administrative_expense| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $387.25M | $387.25M | $387.25M | $387.25M | $591.00M | $609.00M | $605.00M | $628.00M | $605.00M | $627.00M | $628.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +52.6% | +3.0% | -0.7% | +3.8% | -3.7% | +3.6% | +0.2% |
| YoY Change | — | — | — | — | +52.6% | +57.3% | — | — | +2.4% | +3.0% | +3.8% |